At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.
Organization Overview:
External Innovation is a critical growth lever for Lilly’s portfolio strategy and long-term company success. As internal pipelines are increasingly complemented by external science, the identification, rigorous evaluation, and disciplined advancement of external opportunities represent a substantial and growing investment across the enterprise — one that materially shapes Lilly’s ability to deliver breakthrough medicines. Roughly half of Lilly’s new product launches over the past decade were enabled by external innovation. In Neuroscience, this spans research collaborations, platform and asset licenses, equity investments and acquisitions of private and public companies, across modalities from small molecules and antibodies to oligonucleotides, gene therapies and blood–brain barrier delivery technologies.
Purpose:
The Senior Director, External Innovation owns external innovation strategy and execution for one or more dedicated therapeutic or disease area(s) within Neuroscience (e.g., Neurodegeneration, Pain, Psychiatry/Psychedelics, or Sleep-Awake). This role independently leads partnering projects from opportunity identification through scientific due diligence and recommendation to deal completion, translates strategic theses into deal constructs, and serves as the scientific point of contact for partners, combining deep scientific/technical judgment with strong business and deal-structuring acumen. This role may mentor or directly supervise more junior External Innovation colleagues.
Key Responsibilities:
This role’s responsibilities center on three core areas — Search (identify partners and lead early assessment and triage of opportunities; serve as a key contact for partners), Evaluate (assess opportunities with rigorous scientific, technical and business judgment to identify key risks and inform decisions; lead pre-diligence and own scientific due diligence) and Advance (build organizational conviction and stakeholder alignment so that priority opportunities progress to deal completion and are set up to succeed after close).
Strategy
•Own external innovation strategy and approach for the assigned therapeutic/disease area(s) within Neuroscience; interact independently with senior management to understand internal portfolio and strategic priorities, develop external strategy, and jointly prioritize external opportunities; translate these priorities into explicit search themes, landscapes and go/no-go criteria.
Search
•Identify and search external innovation and/or collaboration opportunities including but not limited to assets, portfolios and platforms, through systematic landscape screens, scientific and partnering conferences, and an active network across biotech, academia, venture capital and pharma; identify partners and lead early assessment of opportunities and triage.
Evaluate
•Lead and be responsible for initial technical evaluations for the designated disease area, including leveraging therapeutic area-specific and cross-functional expertise where appropriate. Own the designated disease area’s in-depth scientific due diligence, applying scientific, technical, and business judgment to identify the critical diligence questions, key opportunities and risks; resolve conflicts and align stakeholders.
•Independently lead partnering projects — including all partner interactions, scientific due diligence, consolidation of feedback into a clear written recommendation (advance, hold or decline, with rationale), preparation of management decks, and collaboration with Corporate Business Development on evolution of deal structure and progression to close.
•Provide timely, constructive scientific feedback to potential partners at each stage of review, nurturing long-term relationships in parallel with evaluations so that Lilly is regarded as a partner of choice.
Advance
•Translate the scientific and strategic thesis into an initial deal construct — including structure, scope, and value rationale, with business terms aligned to key scientific and clinical inflection points — and lead early commercial conversations with partners to test and shape it before formalizing the deal team.
•Build organizational conviction behind priority opportunities through effective stakeholder management across therapeutic area, Business Unit and Corporate Business Development leadership, ensuring alignment to strategic needs as opportunities move toward deal completion.
•Partner effectively with cross-functional colleagues throughout the deal lifecycle — including Due Diligence, Corporate Business Development (Transactions), Alliance & Innovation Management, Legal and Intellectual Property, and the relevant Lilly Research Laboratories and therapeutic area functions — to ensure opportunities are properly vetted, negotiated, and integrated post-close; remain the scientific point of contact through hand-over to the receiving team.
Representation and governance
•Represent external innovation for the assigned area(s) in relevant lead team meetings; contribute to the Neuroscience external innovation deal-flow review with therapeutic area and Corporate Business Development/External Innovation stakeholders; own selection of topics and presentations on the assigned area(s) for senior management forums.
•Maintain deep scientific knowledge of internal portfolio projects, external opportunities, and the competitive landscape for the assigned area(s), spanning discovery, clinical development, and platforms; actively monitor relevant external preclinical- and clinical-stage assets and competitor data readouts.
•Represent Lilly’s strategic and external innovation priorities for the assigned area(s) at external meetings across a broad range of partners; participate in industry roundtables and invited presentations; maintain strong external networks across biotech, venture capital, and pharma.
•Mentor and support junior External Innovation colleagues on deals within the area of interest — reviewing management decks, advising on deal structure, and helping guide partner interactions.
Basic Requirements:
•Bachelor’s degree or higher in a relevant area of science and/or healthcare
•10 years of experience in the pharmaceutical industry, biotech, or ventures
•3 years of experience in external innovation, search and evaluation, business development or venture roles related to the assigned area(s)
Additional Skills/Preferences:
•Ph.D. or equivalent in a relevant area of science is highly preferred
•MBA degree is a plus
•Strong scientific background in the area of interest, with a track record of accomplishments in drug discovery or development
•Deep understanding of neuroscience disease biology, unmet need, target landscape, emerging modalities and technologies (e.g., oligonucleotides, gene therapy and editing, protein degradation, blood–brain barrier delivery), fluid and imaging biomarkers, competition and portfolio trends across neurodegeneration, pain, psychiatry and sleep-wake disorders
•Strong business acumen, with a solid understanding of R&D, commercialization, portfolio strategy, and finance
•Strong understanding of the strategic and financial considerations underlying deal priorities and partner considerations; working knowledge of a wide variety of deal structures and term-sheet economics
•Ability to work effectively and drive success within a highly integrated, cross-functional team — across science, business, finance, legal, Catalyze 360, and Corporate Business Development — to ensure progression and closure of deals
•Ability to set strategy and progress a portfolio of deals within the assigned area(s) with minimal guidance
•Strong ability to influence and manage senior leadership and key stakeholders, both internal and external, with effective team collaboration
•Excellent written and verbal communication skills, including the ability to produce concise, decision-ready written assessments and to present and defend recommendations to senior leadership
•Intellectual honesty and decision-making agility; comfortable with ambiguity and able to prioritize multiple concurrent evaluations
•Familiarity with AI-enabled landscape, competitive-intelligence and scouting tools
•Experience in new company creation, venture capital interactions, or spinout management
•Track record of successful partnership execution (deal sheet preferred)
Additional Information:
•Travel: 25–40%, including international
Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form ( https://careers.lilly.com/us/en/workplace-accommodation ) for further assistance. Please note this is for individuals to request an accommodation as part of the application process and any other correspondence will not receive a response.
Lilly is proud to be an EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status.
Our employee resource groups (ERGs) offer strong support networks for their members and are open to all employees. Our current groups include: Africa, Middle East, Central Asia (AMECA), Black Employees at Lilly (BE Lilly), Chinese Culture Network (CCN), EnAble, Evolve, Lilly Indian Network (LIN), Organization of Latinx at Lilly (OLA), Pride (LGBTQ Allies), Veterans Leadership Network (VLN) and Women’s Initiative for Leading at Lilly (WILL).
Actual compensation will depend on a candidate’s education, experience, skills, and geographic location. The anticipated wage for this position is
$175,500 - $257,400
Full-time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance). In addition, Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company-sponsored 401(k); pension; vacation benefits; eligibility for medical, dental, vision and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities).Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly’s compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees.
#WeAreLilly